The primary treatment approach for individuals diagnosed with Alzheimer's disease involves the use of centrally acting acetylcholinesterase inhibitors aimed at mitigating the loss of acetylcholine in the brain (Hamulakova et al., 2016[181]). Here, ACHE is linked to Alzheimer disease.